CONMED Corporation to Announce Fourth Quarter 2023 Financial Results on January 31, 2024

Rhea-AI Summary

CONMED Corporation (CNMD) to report Q4 2023 financial results on January 31, 2024. Conference call scheduled for 4:30 p.m. ET on the same day.

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2023 after the market close on Wednesday, January 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode.

This conference call will also be webcast and can be accessed from the “Investors” section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

About CONMED Corporation

CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release and associated conference call may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2022, listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q and other risks and uncertainties, which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240103343547/en/

CONMED Corporation

Todd W. Garner

Chief Financial Officer

727-214-2975

ToddGarner@conmed.com

Source: CONMED Corporation

FAQ

When will CONMED Corporation report its Q4 2023 financial results?

CONMED Corporation (CNMD) will report its Q4 2023 financial results after the market close on Wednesday, January 31, 2024.

What time is the conference call to discuss CONMED Corporation's Q4 2023 financial results?

The conference call to discuss CONMED Corporation's Q4 2023 financial results is scheduled for 4:30 p.m. ET on Wednesday, January 31, 2024.

How can I participate in CONMED Corporation's conference call?

To participate in the conference call via telephone, please pre-register and obtain the dial-in number and passcode on CONMED Corporation's website.

Where can I access the webcast replay of CONMED Corporation's conference call?

The webcast replay of CONMED Corporation's conference call will be available in the 'Investors' section of CONMED's website approximately one hour after the end of the call.